AdaptHealth shareholders approve de-staggered board, officer exculpation, and 8.35M share increase to equity plan

AdaptHealth Corp.

Shareholders approved board declassification; directors elected after 2024 will serve one-year terms, phase-out complete by 2026.
Stockholders approved officer exculpation amendment to certificate of incorporation under new Delaware law.
8,350,000 new shares added to 2019 Stock Incentive Plan; plan termination date extended to 2034.
Directors Terence Connors, Ted Lundberg, Joshua Parnes, David Williams III elected to one-year terms.
KPMG LLP ratified as independent auditor for FY 2024; advisory say-on-pay passed with 94.4M votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.